{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:35:08Z","timestamp":1779917708576,"version":"3.53.1"},"publisher-location":"Cham","reference-count":86,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319596587","type":"print"},{"value":"9783319596594","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/164_2016_83","type":"book-chapter","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T07:42:43Z","timestamp":1477035763000},"page":"177-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Partial Adenosine A1 Agonist in Heart Failure"],"prefix":"10.1007","author":[{"given":"Wilfried","family":"Dinh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Albrecht-K\u00fcpper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A.","family":"Voors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"van der Laan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani N.","family":"Sabbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,22]]},"reference":[{"issue":"8","key":"83_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2174\/138161209787582101","volume":"15","author":"K Abozguia","year":"2009","unstructured":"Abozguia K, Shivu GN, Ahmed I et al (2009) The heart metabolism: pathophysiological aspects in ischaemia and heart failure. Curr Pharm Des 15(8):827\u2013835","journal-title":"Curr Pharm Des"},{"issue":"Suppl 1","key":"83_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11302-011-9274-3","volume":"8","author":"BE Albrecht-K\u00fcpper","year":"2012","unstructured":"Albrecht-K\u00fcpper BE, Leineweber K, Nell PG (2012) Partial adenosine A1 receptor agonists for cardiovascular therapies. Purinergic Signal 8(Suppl 1):91\u201399","journal-title":"Purinergic Signal"},{"issue":"11","key":"83_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","volume":"34","author":"AP Ambrosy","year":"2013","unstructured":"Ambrosy AP, Pang PS, Khan S et al (2013) Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J 34(11):835\u2013843","journal-title":"Eur Heart J"},{"issue":"4","key":"83_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCHEARTFAILURE.114.002024","volume":"8","author":"AA Badar","year":"2015","unstructured":"Badar AA, Perez-Moreno AC, Hawkins NM et al (2015) Clinical characteristics and outcomes of patients with coronary artery disease and angina: analysis of the irbesartan in patients with heart failure and preserved systolic function trial. Circ Heart Fail 8(4):717\u2013724","journal-title":"Circ Heart Fail"},{"issue":"3","key":"83_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1071-3581(03)00520-8","volume":"10","author":"M Bajaj","year":"2003","unstructured":"Bajaj M, Defronzo RA (2003) Metabolic and molecular basis of insulin resistance. J Nucl Cardiol 10(3):311\u2013323","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"83_CR6","first-page":"483","volume":"25","author":"M Bayes","year":"2003","unstructured":"Bayes M, Rabasseda X, Prous JR (2003) Gateways to clinical trials. Methods Find Exp Clin Pharmacol 25(6):483\u2013506","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"6","key":"83_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jacc.2012.08.1021","volume":"61","author":"M Bayeva","year":"2013","unstructured":"Bayeva M, Gheorghiade M, Ardehali H (2013) Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol 61(6):599\u2013610","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"83_CR8","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/CIRCHEARTFAILURE.113.000912","volume":"7","author":"M Bayeva","year":"2014","unstructured":"Bayeva M, Sawicki KT, Butler J et al (2014) Molecular and cellular basis of viable dysfunctional myocardium. Circ Heart Fail 7(4):680\u2013691","journal-title":"Circ Heart Fail"},{"issue":"3 Pt 2","key":"83_CR9","first-page":"F482","volume":"263","author":"RE Beach","year":"1992","unstructured":"Beach RE, Good DW (1992) Effects of adenosine on ion transport in rat medullary thick ascending limb. Am J Physiol 263(3 Pt 2):F482\u2013F487","journal-title":"Am J Physiol"},{"issue":"16","key":"83_CR10","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1161\/01.CIR.0000095029.57483.60","volume":"108","author":"D Bello","year":"2003","unstructured":"Bello D, Shah DJ, Farah GM et al (2003) Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 108(16):1945\u20131953","journal-title":"Circulation"},{"key":"83_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1152\/physiol.00019.2006","volume":"21","author":"DM Bers","year":"2006","unstructured":"Bers DM (2006) Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda) 21:380\u2013387","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"83_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4158\/EP.7.1.44","volume":"7","author":"G Boden","year":"2001","unstructured":"Boden G (2001) Free fatty acids-the link between obesity and insulin resistance. Endocr Pract 7(1):44\u201351","journal-title":"Endocr Pract"},{"issue":"Suppl 3","key":"83_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1046\/j.1365-2362.32.s3.3.x","volume":"32","author":"G Boden","year":"2002","unstructured":"Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32(Suppl 3):14\u201323","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"83_CR14","doi-asserted-by":"publisher","first-page":"e18048","DOI":"10.1371\/journal.pone.0018048","volume":"6","author":"L Bott-Flugel","year":"2011","unstructured":"Bott-Flugel L, Bernshausen A, Schneider H et al (2011) Selective attenuation of norepinephrine release and stress-induced heart rate increase by partial adenosine A1 agonism. PLoS One 6(3):e18048","journal-title":"PLoS One"},{"issue":"6","key":"83_CR15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00280-010-1441-7","volume":"67","author":"H Bugger","year":"2011","unstructured":"Bugger H, Guzman C, Zechner C et al (2011) Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation. Cancer Chemother Pharmacol 67(6):1381\u20131388","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2\u20134","key":"83_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.vph.2012.05.003","volume":"57","author":"C Capurso","year":"2012","unstructured":"Capurso C, Capurso A (2012) From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol 57(2\u20134):91\u201397","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"83_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2174\/1568026033392246","volume":"3","author":"AK Dhalla","year":"2003","unstructured":"Dhalla AK, Shryock JC, Shreeniwas R et al (2003) Pharmacology and therapeutic applications of A1 adenosine receptor ligands. Curr Top Med Chem 3(4):369\u2013385","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"83_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1124\/jpet.106.114421","volume":"321","author":"AK Dhalla","year":"2007","unstructured":"Dhalla AK, Santikul M, Smith M et al (2007a) Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid. J Pharmacol Exp Ther 321(1):327\u2013333","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"83_CR19","doi-asserted-by":"publisher","first-page":"E1358","DOI":"10.1152\/ajpendo.00573.2006","volume":"292","author":"AK Dhalla","year":"2007","unstructured":"Dhalla AK, Wong MY, Voshol PJ et al (2007b) A1 adenosine receptor partial agonist lowers plasma FFA and improves insulin resistance induced by high-fat diet in rodents. Am J Physiol Endocrinol Metab 292(5):E1358\u2013E1363","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"83_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-3-540-89615-9_9","volume":"193","author":"AK Dhalla","year":"2009","unstructured":"Dhalla AK, Chisholm JW, Reaven GM et al (2009) A1 adenosine receptor: role in diabetes and obesity. Handb Exp Pharmacol 193:271\u2013295","journal-title":"Handb Exp Pharmacol"},{"key":"83_CR21","doi-asserted-by":"crossref","unstructured":"Dinh W, Voors A, Delesen H et al (2016) Safety and tolerability of neladenoson bialanate, a novel oral partial and selective adenosine A1 receptor agonist, in healthy volunteers pretreated with beta-blocker. Paper presented at the ESC HF Congress 2016, Florence","DOI":"10.1002\/jcph.828"},{"issue":"8","key":"83_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cardfail.2007.08.006","volume":"13","author":"HC Dittrich","year":"2007","unstructured":"Dittrich HC, Gupta DK, Hack TC et al (2007) The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Card Fail 13(8):609\u2013617","journal-title":"J Card Fail"},{"issue":"6","key":"83_CR23","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1476-5381.1996.tb15561.x","volume":"118","author":"AK Dixon","year":"1996","unstructured":"Dixon AK, Gubitz AK, Sirinathsinghji DJ et al (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118(6):1461\u20131468","journal-title":"Br J Pharmacol"},{"issue":"5","key":"83_CR24","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/CIRCHEARTFAILURE.113.000521","volume":"6","author":"L Djouss\u00e9","year":"2013","unstructured":"Djouss\u00e9 L, Benkeser D, Arnold A et al (2013) Plasma free fatty acids and risk of heart failure: the Cardiovascular Health Study. Circ Heart Fail 6(5):964\u2013969","journal-title":"Circ Heart Fail"},{"issue":"24","key":"83_CR25","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1161\/CIRCULATIONAHA.104.510982","volume":"111","author":"KA Ellenbogen","year":"2005","unstructured":"Ellenbogen KA, O\u2019Neill G, Prystowsky EN et al (2005) Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson. Circulation 111(24):3202\u20133208","journal-title":"Circulation"},{"key":"83_CR26","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA et al (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53(4):527\u2013552"},{"issue":"11","key":"83_CR27","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/CIRCULATIONAHA.106.623199","volume":"114","author":"M Gheorghiade","year":"2006","unstructured":"Gheorghiade M, Sopko G, De Luca L et al (2006) Navigating the crossroads of coronary artery disease and heart failure. Circulation 114(11):1202\u20131213","journal-title":"Circulation"},{"issue":"16","key":"83_CR28","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.jacc.2007.07.019","volume":"50","author":"MM Givertz","year":"2007","unstructured":"Givertz MM, Massie BM, Fields TK et al (2007) The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 50(16):1551\u20131560","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"83_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10741-015-9522-7","volume":"21","author":"SJ Greene","year":"2016","unstructured":"Greene SJ, Sabbah HN, Butler J et al (2016) Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure. Heart Fail Rev 21(1):95\u2013102","journal-title":"Heart Fail Rev"},{"issue":"3","key":"83_CR30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/01.RES.75.3.434","volume":"75","author":"G Hasenfuss","year":"1994","unstructured":"Hasenfuss G, Reinecke H, Studer R et al (1994) Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res 75(3):434\u2013442","journal-title":"Circ Res"},{"issue":"5","key":"83_CR31","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1006\/jmcc.1998.0672","volume":"30","author":"JP Headrick","year":"1998","unstructured":"Headrick JP, Gauthier NS, Berr SS et al (1998) Transgenic A1 adenosine receptor overexpression markedly improves myocardial energy state during ischemia-reperfusion. J Mol Cell Cardiol 30(5):1059\u20131064","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"83_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF00944394","volume":"144","author":"L Heseltine","year":"1995","unstructured":"Heseltine L, Webster JM, Taylor R (1995) Adenosine effects upon insulin action on lipolysis and glucose transport in human adipocytes. Mol Cell Biochem 144(2):147\u2013151","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"83_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/01.RES.77.1.194","volume":"77","author":"T Hussain","year":"1995","unstructured":"Hussain T, Mustafa SJ (1995) Binding of A1 adenosine receptor ligand [3H]8-cyclopentyl-1,3-dipropylxanthine in coronary smooth muscle. Circ Res 77(1):194\u2013198","journal-title":"Circ Res"},{"issue":"3","key":"83_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1021\/jm00081a001","volume":"35","author":"KA Jacobson","year":"1992","unstructured":"Jacobson KA, van Galen PJ, Williams M (1992) Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem 35(3):407\u2013422","journal-title":"J Med Chem"},{"issue":"2","key":"83_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1042\/cs0820219","volume":"82","author":"AB Johnson","year":"1992","unstructured":"Johnson AB, Argyraki M, Thow JC et al (1992) Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man. Clin Sci (Lond) 82(2):219\u2013226","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"83_CR36","doi-asserted-by":"publisher","first-page":"F1847","DOI":"10.1152\/ajprenal.00336.2007","volume":"293","author":"JD Joo","year":"2007","unstructured":"Joo JD, Kim M, Horst P et al (2007) Acute and delayed renal protection against renal ischemia and reperfusion injury with A1 adenosine receptors. Am J Physiol Renal Physiol 293(6):F1847\u2013F1857","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3 Pt 2","key":"83_CR37","first-page":"H820","volume":"259","author":"GE Kirsch","year":"1990","unstructured":"Kirsch GE, Codina J, Birnbaumer L et al (1990) Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes. Am J Physiol 259(3 Pt 2):H820\u2013H826","journal-title":"Am J Physiol"},{"issue":"2","key":"83_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11897-008-0013-1","volume":"5","author":"KR Laskowski","year":"2008","unstructured":"Laskowski KR, Russell RR 3rd (2008) Uncoupling proteins in heart failure. Curr Heart Fail Rep 5(2):75\u201379","journal-title":"Curr Heart Fail Rep"},{"issue":"9","key":"83_CR39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1161\/01.CIR.100.9.999","volume":"100","author":"DL Mann","year":"1999","unstructured":"Mann DL (1999) Mechanisms and models in heart failure: a combinatorial approach. Circulation 100(9):999\u20131008","journal-title":"Circulation"},{"issue":"15","key":"83_CR40","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","volume":"363","author":"BM Massie","year":"2010","unstructured":"Massie BM, O'Connor CM, Metra M et al (2010) Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363(15):1419\u20131428","journal-title":"N Engl J Med"},{"issue":"12","key":"83_CR41","doi-asserted-by":"publisher","first-page":"6541","DOI":"10.1073\/pnas.94.12.6541","volume":"94","author":"GP Matherne","year":"1997","unstructured":"Matherne GP, Linden J, Byford AM et al (1997) Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci U S A 94(12):6541\u20136546","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"83_CR42","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1172\/JCI106621","volume":"50","author":"OD Mjos","year":"1971","unstructured":"Mjos OD (1971a) Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 50(7):1386\u20131389","journal-title":"J Clin Invest"},{"issue":"9","key":"83_CR43","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1172\/JCI106679","volume":"50","author":"OD Mjos","year":"1971","unstructured":"Mjos OD (1971b) Effect of inhibition of lipolysis on myocardial oxygen consumption in the presence of isoproterenol. J Clin Invest 50(9):1869\u20131873","journal-title":"J Clin Invest"},{"issue":"2 Pt 2","key":"83_CR44","first-page":"H769","volume":"272","author":"VK Mootha","year":"1997","unstructured":"Mootha VK, Arai AE, Balaban RS (1997) Maximum oxidative phosphorylation capacity of the mammalian heart. Am J Physiol 272(2 Pt 2):H769\u2013H775","journal-title":"Am J Physiol"},{"issue":"3","key":"83_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12265-015-9618-4","volume":"8","author":"SR Motiwala","year":"2015","unstructured":"Motiwala SR, Gaggin HK, Gandhi PU et al (2015) Concentrations of highly sensitive cardiac troponin-I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure. J Cardiovasc Transl Res 8(3):164\u2013172","journal-title":"J Cardiovasc Transl Res"},{"issue":"1","key":"83_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0008-6363(01)00358-3","volume":"52","author":"K Mubagwa","year":"2001","unstructured":"Mubagwa K, Flameng W (2001) Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc Res 52(1):25\u201339","journal-title":"Cardiovasc Res"},{"issue":"2","key":"83_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0922-4106(93)90086-O","volume":"246","author":"B Musser","year":"1993","unstructured":"Musser B, Morgan ME, Leid M et al (1993) Species comparison of adenosine and beta-adrenoceptors in mammalian atrial and ventricular myocardium. Eur J Pharmacol 246(2):105\u2013111","journal-title":"Eur J Pharmacol"},{"key":"83_CR48","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-3-540-89615-9_6","volume":"193","author":"SJ Mustafa","year":"2009","unstructured":"Mustafa SJ, Morrison RR, Teng B et al (2009) Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol 193:161\u2013188","journal-title":"Handb Exp Pharmacol"},{"key":"83_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0079-6468(08)00204-X","volume":"47","author":"PG Nell","year":"2009","unstructured":"Nell PG, Albrecht-Kupper B (2009) The adenosine A1 receptor and its ligands. Prog Med Chem 47:163\u2013201","journal-title":"Prog Med Chem"},{"issue":"11","key":"83_CR50","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S (2007) The failing heart\u2013an engine out of fuel. N Engl J Med 356(11):1140\u20131151","journal-title":"N Engl J Med"},{"issue":"16","key":"83_CR51","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1056\/NEJM199704173361603","volume":"336","author":"G Olivetti","year":"1997","unstructured":"Olivetti G, Abbi R, Quaini F et al (1997) Apoptosis in the failing human heart. N Engl J Med 336(16):1131\u20131141","journal-title":"N Engl J Med"},{"issue":"2","key":"83_CR52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0021-9258(19)75863-3","volume":"262","author":"WJ Parsons","year":"1987","unstructured":"Parsons WJ, Stiles GL (1987) Heterologous desensitization of the inhibitory A1 adenosine receptor-adenylate cyclase system in rat adipocytes. Regulation of both Ns and Ni. J Biol Chem 262(2):841\u2013847","journal-title":"J Biol Chem"},{"issue":"6","key":"83_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/01.crd.0000181621.84565.9d","volume":"13","author":"C Peterman","year":"2005","unstructured":"Peterman C, Sanoski CA (2005) Tecadenoson: a novel, selective A1 adenosine receptor agonist. Cardiol Rev 13(6):315\u2013321","journal-title":"Cardiol Rev"},{"issue":"5","key":"83_CR54","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jacc.2009.05.012","volume":"54","author":"TT Phan","year":"2009","unstructured":"Phan TT, Abozguia K, Nallur Shivu G et al (2009) Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. J Am Coll Cardiol 54(5):402\u2013409","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"83_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1161\/CIRCHEARTFAILURE.109.877720","volume":"3","author":"TT Phan","year":"2010","unstructured":"Phan TT, Shivu GN, Abozguia K et al (2010) Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circ Heart Fail 3(1):29\u201334","journal-title":"Circ Heart Fail"},{"issue":"1","key":"83_CR56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/bph.13339","volume":"173","author":"SL Puhl","year":"2016","unstructured":"Puhl SL, Kazakov A, Muller A et al (2016) Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to alpha1-adrenoceptor stimulation in vivo. Br J Pharmacol 173(1):88\u2013102","journal-title":"Br J Pharmacol"},{"issue":"24","key":"83_CR57","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1161\/hc4901.100526","volume":"104","author":"P Razeghi","year":"2001","unstructured":"Razeghi P, Young ME, Alcorn JL et al (2001) Metabolic gene expression in fetal and failing human heart. Circulation 104(24):2923\u20132931","journal-title":"Circulation"},{"key":"83_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainres.2007.11.044","volume":"1191","author":"V Roman","year":"2008","unstructured":"Roman V, Keijser JN, Luiten PG et al (2008) Repetitive stimulation of adenosine A1 receptors in vivo: changes in receptor numbers, G-proteins and A1 receptor agonist-induced hypothermia. Brain Res 1191:69\u201374","journal-title":"Brain Res"},{"issue":"25","key":"83_CR59","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.2174\/138161208786071317","volume":"14","author":"GM Rosano","year":"2008","unstructured":"Rosano GM, Fini M, Caminiti G et al (2008) Cardiac metabolism in myocardial ischemia. Curr Pharm Des 14(25):2551\u20132562","journal-title":"Curr Pharm Des"},{"issue":"9","key":"83_CR60","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/ejhf.142","volume":"16","author":"D Rusinaru","year":"2014","unstructured":"Rusinaru D, Houpe D, Szymanski C et al (2014) Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction. Eur J Heart Fail 16(9):967\u2013976","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"83_CR61","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0008-6363(99)00348-X","volume":"45","author":"HN Sabbah","year":"2000","unstructured":"Sabbah HN (2000) Apoptotic cell death in heart failure. Cardiovasc Res 45(3):704\u2013712","journal-title":"Cardiovasc Res"},{"issue":"11","key":"83_CR62","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/0022-2828(92)93098-5","volume":"24","author":"HN Sabbah","year":"1992","unstructured":"Sabbah HN, Sharov V, Riddle JM et al (1992) Mitochondrial abnormalities in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 24(11):1333\u20131347","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"83_CR63","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1161\/01.CIR.89.6.2852","volume":"89","author":"HN Sabbah","year":"1994","unstructured":"Sabbah HN, Shimoyama H, Kono T et al (1994) Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 89(6):2852\u20132859","journal-title":"Circulation"},{"issue":"3","key":"83_CR64","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1161\/CIRCHEARTFAILURE.112.000208","volume":"6","author":"HN Sabbah","year":"2013","unstructured":"Sabbah HN, Gupta RC, Kohli S et al (2013) Chronic therapy with a partial adenosine A1-receptor agonist improves left ventricular function and remodeling in dogs with advanced heart failure. Circ Heart Fail 6(3):563\u2013571","journal-title":"Circ Heart Fail"},{"issue":"4","key":"83_CR65","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/01.HYP.0000183963.07801.65","volume":"46","author":"F Schweda","year":"2005","unstructured":"Schweda F, Segerer F, Castrop H et al (2005) Blood pressure-dependent inhibition of Renin secretion requires A1 adenosine receptors. Hypertension 46(4):780\u2013786","journal-title":"Hypertension"},{"issue":"3","key":"83_CR66","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cardfail.2009.11.007","volume":"16","author":"RV Shah","year":"2010","unstructured":"Shah RV, Desai AS, Givertz MM (2010) The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis. J Card Fail 16(3):260\u2013267","journal-title":"J Card Fail"},{"issue":"9","key":"83_CR67","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1006\/jmcc.1998.0739","volume":"30","author":"VG Sharov","year":"1998","unstructured":"Sharov VG, Goussev A, Lesch M et al (1998) Abnormal mitochondrial function in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 30(9):1757\u20131762","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"83_CR68","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1006\/jmcc.2000.1266","volume":"32","author":"VG Sharov","year":"2000","unstructured":"Sharov VG, Todor AV, Silverman N et al (2000) Abnormal mitochondrial respiration in failed human myocardium. J Mol Cell Cardiol 32(12):2361\u20132367","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"83_CR69","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1124\/jpet.108.143594","volume":"328","author":"J Shearer","year":"2009","unstructured":"Shearer J, Severson DL, Su L et al (2009) Partial A1 adenosine receptor agonist regulates cardiac substrate utilization in insulin-resistant rats in vivo. J Pharmacol Exp Ther 328(1):306\u2013311","journal-title":"J Pharmacol Exp Ther"},{"issue":"12A","key":"83_CR70","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0002-9149(97)00256-7","volume":"79","author":"JC Shryock","year":"1997","unstructured":"Shryock JC, Belardinelli L (1997) Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79(12A):2\u201310","journal-title":"Am J Cardiol"},{"issue":"1","key":"83_CR71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/B:HREV.0000011393.40674.13","volume":"9","author":"DA Siwik","year":"2004","unstructured":"Siwik DA, Colucci WS (2004) Regulation of matrix metalloproteinases by cytokines and reactive oxygen\/nitrogen species in the myocardium. Heart Fail Rev 9(1):43\u201351","journal-title":"Heart Fail Rev"},{"issue":"4","key":"83_CR72","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/mol.52.4.683","volume":"52","author":"M Srinivas","year":"1997","unstructured":"Srinivas M, Shryock JC, Dennis DM et al (1997) Differential A1 adenosine receptor reserve for two actions of adenosine on guinea pig atrial myocytes. Mol Pharmacol 52(4):683\u2013691","journal-title":"Mol Pharmacol"},{"issue":"4","key":"83_CR73","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/jcph.9","volume":"53","author":"PM Staehr","year":"2013","unstructured":"Staehr PM, Dhalla AK, Zack J et al (2013) Reduction of free fatty acids, safety, and pharmacokinetics of oral GS-9667, an A(1) adenosine receptor partial agonist. J Clin Pharmacol 53(4):385\u2013392","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"83_CR74","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","volume":"126","author":"BA Steinberg","year":"2012","unstructured":"Steinberg BA, Zhao X, Heidenreich PA et al (2012) Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 126(1):65\u201375","journal-title":"Circulation"},{"key":"83_CR75","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/978-3-540-89615-9_17","volume":"193","author":"TW Stone","year":"2009","unstructured":"Stone TW, Ceruti S, Abbracchio MP (2009) Adenosine receptors and neurological disease: neuroprotection and neurodegeneration. Handb Exp Pharmacol 193:535\u2013587","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"83_CR76","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2165\/11594680-000000000-00000","volume":"35","author":"JR Teerlink","year":"2012","unstructured":"Teerlink JR, Iragui VJ, Mohr JP et al (2012) The safety of an adenosine A1-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT. Drug Saf 35(3):233\u2013244","journal-title":"Drug Saf"},{"issue":"7","key":"83_CR77","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00392-012-0430-8","volume":"101","author":"M Tendera","year":"2012","unstructured":"Tendera M, Gaszewska-Zurek E, Parma Z et al (2012) The new oral adenosine A1 receptor agonist capadenoson in male patients with stable angina. Clin Res Cardiol 101(7):585\u2013591","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"83_CR78","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","volume":"116","author":"T Thum","year":"2007","unstructured":"Thum T, Galuppo P, Wolf C et al (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116(3):258\u2013267","journal-title":"Circulation"},{"issue":"20","key":"83_CR79","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1161\/CIRCULATIONAHA.106.645184","volume":"114","author":"H Tuunanen","year":"2006","unstructured":"Tuunanen H, Engblom E, Naum A et al (2006) Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 114(20):2130\u20132137","journal-title":"Circulation"},{"issue":"2","key":"83_CR80","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrcardio.2012.181","volume":"10","author":"M Vaduganathan","year":"2013","unstructured":"Vaduganathan M, Greene SJ, Ambrosy AP et al (2013) The disconnect between phase II and phase III trials of drugs for heart failure. Nat Rev Cardiol 10(2):85\u201397","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"83_CR81","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1161\/CIRCHEARTFAILURE.115.002271","volume":"8","author":"M Vaduganathan","year":"2015","unstructured":"Vaduganathan M, Butler J, Pitt B et al (2015) Contemporary drug development in heart failure: call for hemodynamically neutral therapies. Circ Heart Fail 8(4):826\u2013831","journal-title":"Circ Heart Fail"},{"issue":"3","key":"83_CR82","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1152\/physrev.00031.2005","volume":"86","author":"V Vallon","year":"2006","unstructured":"Vallon V, Muhlbauer B, Osswald H (2006) Adenosine and kidney function. Physiol Rev 86(3):901\u2013940","journal-title":"Physiol Rev"},{"issue":"2","key":"83_CR83","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ejheart.2008.01.010","volume":"10","author":"V Vallon","year":"2008","unstructured":"Vallon V, Miracle C, Thomson S (2008) Adenosine and kidney function: potential implications in patients with heart failure. Eur J Heart Fail 10(2):176\u2013187","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"83_CR84","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/s-0029-1186271","volume":"58","author":"G Veres","year":"2010","unstructured":"Veres G, Radovits T, Otila G et al (2010) Efficacy of the non-adenosine analogue A1 adenosine receptor agonist (BR-4935) on cardiovascular function after cardiopulmonary bypass. Thorac Cardiovasc Surg 58(2):86\u201392","journal-title":"Thorac Cardiovasc Surg"},{"issue":"3","key":"83_CR85","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1440-1681.2009.05300.x","volume":"37","author":"F Xiang","year":"2010","unstructured":"Xiang F, Huang YS, Zhang DX et al (2010) Adenosine A1 receptor activation reduces opening of mitochondrial permeability transition pores in hypoxic cardiomyocytes. Clin Exp Pharmacol Physiol 37(3):343\u2013349","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"83_CR86","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/01.CIR.88.1.235","volume":"88","author":"Z Yao","year":"1993","unstructured":"Yao Z, Gross GJ (1993) Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium. Circulation 88(1):235\u2013244","journal-title":"Circulation"}],"container-title":["Handbook of Experimental Pharmacology","Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2016_83","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T22:35:36Z","timestamp":1657492536000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2016_83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319596587","9783319596594"],"references-count":86,"URL":"https:\/\/doi.org\/10.1007\/164_2016_83","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"22 October 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}